Menu
Back to Journals » Hepatic Medicine: Evidence and Research » Volume 14
Original Research
Post-Marketing Surveillance Study of the Safety and Efficacy of Nalfurafine (Capsules 2.5 μg, Oral Dispersing Tablets 2.5 μg) in 1186 Patients with Chronic Liver Disease and Intractable Pruritus
| Total article views | HTML views | PDF downloads | Totals | ||
|---|---|---|---|---|---|
| 6,270 | Dovepress* | 6,040+ | 327 | 6,367 | |
| PubMed Central* | 230 | 93 | 323 | ||
| Totals | 6,270 | 420 | 6,690 | ||
| *Since 2 May 2022 | |||||
View citations on PubMed Central and Google Scholar